XRAY - DENTSPLY SIRONA Inc.
CHARLOTTE, N.C., May 20, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 2026 Stifel Jaws & Paws Conference. Management is scheduled to present on Wednesday, May 27, 2026, at 3:35 p.m. ET.
DENTSPLY SIRONA stock slips after Q1 earnings miss estimates as margin pressure offsets revenue growth in key healthcare segments.
DENTSPLY SIRONA Inc. (XRAY) Q1 2026 Earnings Call Transcript
The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Dentsply International (XRAY) came out with quarterly earnings of $0.27 per share, missing the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.43 per share a year ago.
News Summary Reported net sales of $880 million Delivered GAAP gross margin of 48.5% , GAAP net loss per share of ($0.05) Achieved adjusted gross margin of 50.7% , adjusted EBITDA margin of 14.7% , adjusted EPS of $0.27 Launched Smart View-Detect, the world's first FDA-cleared, AI-enabled diagnostic aid designed to identify teeth with periapical radiolucencies (PARL) in CBCT scans, now also CE-marked for use across Europe Continued to penetrate connected technology solutions market with new Atlanta Dental Supply distributor agreement Installed first CEREC ® system under the new Benco Dental distribution agreement, marking an important early milestone Began implementing new capital allocation strategy by reducing debt, managing liquidity, and improving working capital Reiterated 2026 outlook for net sales and adjusted EPS CHARLOTTE, N.C., May 05, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the first quarter of 2026.
CHARLOTTE, N.C., May 04, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona (Nasdaq: XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced an enhanced distribution agreement with Atlanta Dental Supply, under which Atlanta Dental will begin offering Dentsply Sirona's connected technology solutions portfolio in the United States as of August 1.
XRAY heads into Q1 earnings with U.S. softness, tariff pressure and transformation costs weighing on margins as investors watch for signs of stabilization.
Becton Dickinson (BDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dentsply (XRAY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cwm LLC reduced its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) by 54.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 191,766 shares of the medical instruments supplier's stock after selling 228,704 shares during the quarter. Cwm LLC owned approximately
CHARLOTTE, N.C., April 22, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Tuesday, May 5, 2026, at 4:30 p.m. ET to review its first quarter 2026 financial results. Financial earnings materials will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call.
DENTSPLY SIRONA Inc. (NASDAQ: XRAY - Get Free Report) has been assigned an average rating of "Hold" from the fifteen research firms that are presently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating
XRAY bets on digital workflows and R&D expansion to fuel growth, but forex pressure and weak Europe demand cloud its near-term outlook.
Gregory Lucier acquired 15,000 shares for a total of approximately ~$187,000 on March 9, 2026. No direct holdings were involved in the transaction; all shares are held indirectly via trusts or similar entities.
Dentsply Sirona and Siemens Healthineers win FDA clearance for the first dental-dedicated MRI designed to improve soft-tissue dental imaging and diagnostics.
DENTSPLY SIRONA Inc. (XRAY) Presents at Leerink Global Healthcare Conference 2026 Transcript
A handful of the industry's income-generating gems are hiding in plain sight.
Dentsply Sirona and Siemens Healthineers are pleased to announce that the first-ever dental-dedicated MRI 1 (ddMRI) system – MAGNETOM Free.Max Dental Edition – has received FDA clearance in the United States. This milestone follows the completion of a clinical trial 2 validating the system's significant potential across multiple dental specialties. The trial highlighted this first-of-its-kind technology's applicability in endodontics, periodontics, TMJ, tooth extraction, and orthodontics, offering non-ionizing imaging capabilities that can enhance diagnosis and treatment planning.
Shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY - Get Free Report) fell 7.5% during trading on Friday. The stock traded as low as $12.31 and last traded at $12.33. 662,151 shares were traded during mid-day trading, a decline of 87% from the average session volume of 4,911,188 shares. The stock had previously closed at $13.33.